Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
La Revue De Medecine Interne
|
March 10, 2001
[Psychological and behavioral disorders with good outcome in neurosarcoidosis]
B Granel, C Gaudy, J Serratrice, et al.
Journal of Viral Hepatitis
|
January 25, 2007
Is hepatitis C virus NS3 protease quasispecies heterogeneity predictive of progression from cirrhosis to hepatocellular carcinoma?
S Vallet, S Gouriou, G Nkontchou, et al.
ESMO Open
|
May 26, 2026
Concordance of pathologic response assessment between local and central review in melanoma: a post hoc analysis of KEYMAKER-U02 substudy 02C
M Tetzlaff, J M Taube, G V Long, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 25, 2021
Position statement on classification of basal cell carcinomas. Part 1: unsupervised clustering of experts as a way to build an operational classification of advanced basal cell carcinoma based on pattern recognition
J J Grob, A Guminski, J Malvehy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 23, 2021
Position statement on classification of basal cell carcinomas. Part 2: EADO proposal for new operational staging system adapted to basal cell carcinomas
J J Grob, C Gaudy-Marqueste, A Guminski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2024
Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study
G V Long, M S Carlino, C McNeil, et al.
ESMO Open
|
May 9, 2025
Early switch from run-in with targeted to immunotherapy in advanced BRAF<sup>V600</sup>-positive melanoma: final results of the randomised phase II ImmunoCobiVem trial
E Livingstone, H J Gogas, L Kandolf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 9, 2020
ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee
O Michielin, A van Akkooi, P Lorigan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 9, 2020
ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee
U Keilholz, P A Ascierto, R Dummer, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
July 26, 2015
Identification of a duplicated V3 domain in NS5A associated with cirrhosis and hepatocellular carcinoma in HCV-1b patients
H Le Guillou-Guillemette, A Ducancelle, S Bertrais, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
La Revue De Medecine Interne
|
March 10, 2001
[Psychological and behavioral disorders with good outcome in neurosarcoidosis]
B Granel, C Gaudy, J Serratrice, et al.
Journal of Viral Hepatitis
|
January 25, 2007
Is hepatitis C virus NS3 protease quasispecies heterogeneity predictive of progression from cirrhosis to hepatocellular carcinoma?
S Vallet, S Gouriou, G Nkontchou, et al.
ESMO Open
|
May 26, 2026
Concordance of pathologic response assessment between local and central review in melanoma: a post hoc analysis of KEYMAKER-U02 substudy 02C
M Tetzlaff, J M Taube, G V Long, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 25, 2021
Position statement on classification of basal cell carcinomas. Part 1: unsupervised clustering of experts as a way to build an operational classification of advanced basal cell carcinoma based on pattern recognition
J J Grob, A Guminski, J Malvehy, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
August 23, 2021
Position statement on classification of basal cell carcinomas. Part 2: EADO proposal for new operational staging system adapted to basal cell carcinomas
J J Grob, C Gaudy-Marqueste, A Guminski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2024
Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study
G V Long, M S Carlino, C McNeil, et al.
ESMO Open
|
May 9, 2025
Early switch from run-in with targeted to immunotherapy in advanced BRAF<sup>V600</sup>-positive melanoma: final results of the randomised phase II ImmunoCobiVem trial
E Livingstone, H J Gogas, L Kandolf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 9, 2020
ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee
O Michielin, A van Akkooi, P Lorigan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 9, 2020
ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee
U Keilholz, P A Ascierto, R Dummer, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
July 26, 2015
Identification of a duplicated V3 domain in NS5A associated with cirrhosis and hepatocellular carcinoma in HCV-1b patients
H Le Guillou-Guillemette, A Ducancelle, S Bertrais, et al.
Page
of 8